The response to synaptic glutamate release is produced via activation of a variety of ionotropic and metabotropic glutamate receptor (mGluR) subtypes, which are widely expressed in both neurons and glia throughout the CNS (Nakanishi and Masu, 1994) . The ionotropic glutamate receptors are comprised of multiple subunits that together form an integral cation channel con-ducting sodium or calcium. In contrast, the mGluRs are large monomeric receptors that exert their effects either on second messengers or ion channels via activation of G-proteins; eight subtypes have been identified to date (Nakanishi and Masu, 1994; Schoepp, 1994; Pin and Duvoisin, 1995) . Activation of the mGluR subtypes can produce either excitatory or inhibitory effects through a variety of signal transduction mechanisms, of which the most extensively studied are the phospholipase C-mediated stimulation of phosphoinositide (PI) hydrolysis and the inhibition of adenylate cyclase activity. Additional transduction mechanisms include direct G-protein coupling to calcium and potassium channels and stimulations of adenylate cyclase, phospholipase D, phospholipase A,, and a cyclic GMPdependent phosphodiesterase (Nakanishi and Masu, 1994; Schoepp, 1994; Pin and Duvoisin, 199.5) . Interestingly, application of mGluR agonists has been shown to produce either neuroprotective or neuropathological effects, depending upon the preparation studied (for a review see Miller et al., 1995) . Although some of the mGluR subtypes are known to be expressed in glia, characterization of mGluR function has received less attention in these cells than in their neuronal counterparts.
Astroglia are major components of glutamatergic pathways. Their processes envelop glutamatergic synapses and they have important roles in maintaining glutamatergic transmission by transporting glutamate out of the extracellular space (Schousboe et al., 1988; Flott and Seifert, 1991) and converting it to glutamine through the glial-specific enzyme glutamine synthetase (Schousboe and Hertz, 1981) . Trauma, ischemia, and many neurodegenerative diseases produce a glial reaction characterized by astrocyte proliferation, morphological changes, and induction of the expression of the glial-specific marker glial fibrillary acidic protein (GFAP; for reviews see Hatten et al., 1991; Eng et al., 1992) . This astrogliosis may aid neuronal survival by contributing to the restoration of the blood-brain barrier and through the production of growth factors, neurotrophins, and extracellular matrix components that support neurite growth (Hatten et al., 1991; Eng et al., 1992) . Paradoxically, however, astrogliosis may also inhibit recovery of function through the formation of glial scarring, which forms a physical barrier to the regrowth of axons (Reier and Houle, 1988 press a wide range of neurotransmitter receptors and voltagesensitive channels and synthesize and release neurotransmitters and neuromodulators, indicating that these cells have the potential for dynamic communication with neurons and other astrocytes (Barres, 1991; Martin, 1992) . We recently reported that when astrocytes are cultured in a serum-free defined medium (ADM, astrocyte defined medium) rather than with conventional serum-supplemented media, the ability of the mGluR agonist 1 -aminocyclopentane-trun.y-( +)-dicarboxylic acid [~mns-( k)-ACPD] to stimulate PI hydrolysis is dramatically enhanced (Miller et al., 1993) . This finding suggests that mGluR transduction pathways in astrocytes are plastic and can be modified according to the conditions in the astrocyte's microenvironment.
In the present report, we examined the mechanism underlying this effect and demonstrate that an induction in the expression of mGluR5 correlates with the enhanced PI response. Further, modulation of the growth factor content of our serum-free medium revealed that exposure of the astrocytes to basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), or transforming growth factor-a (TGF-a) will both induce the expression of mGluR5 and enhance the ability of tuuns-(+)-ACPD to stimulate PI hydrolysis. For the final 24 hr of culture, 'H-myo-inositol (I kCi/ well) was added to the culture medium.
Materials and Methods
Prior to addition of agonists, culture medium was aspirated and the cultures rinsed and preincubated for 20 min in buffer containing:
10 mM LiCl (to inhibit /nyo-inositol-1 -phosphatase), 116 mM NaQ26.2 mM NaHCO,, I mM NaH2P0,, 2 (1:2) to each well. Wells were scraped and radioactivity in a sample of this extract was quantified with liquid scintillation counting to measure total incorporation of radiolabel into the cultures. The remainder of the extract was collected and the wells were subsequently rinsed with 0.75 ml of water that was combined with the chloroform:methanol extract and an additional 0.5 ml of chloroform. The aqueous phase was separated by centrifugation (1000 X ,q, IO min) and processed for isolation of 'H-IP, using anion exchange chromatography with Dowex l-X8 columns essentially as described (Milani et al., 1989) 
Results
Trans-(+)-ACPD application (500 pM, 30 min) produced only small increases in 'H-IP, accumulation (less than twofold of basal levels) when astrocytes were maintained in secondary culture in DMEM + 10% FCS (Fig. 1) . However, astrocytes cultured in ADM responded to tram-( +)-ACPD with a large stimulation of PI hydrolysis (34.2 5 4.4-fold of basal, Fig. 1 ). As we previously reported, culturing in ADM also altered astrocyte GFAP immunoreactivity (Miller et al., 1993) . Rather than demonstrating the flat polygonal morphology typical of astrocytes grown in serum-supplemented medium, GFAP immunostaining of ADM cultures showed a highly branched, stellate morphology more similar to the morphology of astrocytes in viva.
Western immunohlotting for PI-coupled mGluRs. To determine if alteration in receptor expression was involved in the increase in PI signal when astrocytes were grown in ADM, we examined the levels of the mGluRs using Western blotting. Of the eight mGluR subtypes that have been characterized, two of these, mGluR1 and mGluR5, have been shown to be able to couple to PI hydrolysis (Abe et al., 1992; Aramori and Nakanishi, 1992) . We investigated expression of these two subtypes using antibodies selective for either mGluRla or mGluR.5. In situ hybridization and immunohistochemistry of brain slices have shown that mGluR1 is restricted to neuronal elements Gores et al., 1993) . Accordingly, no expression of mGluRlol was detected in membranes prepared from astrocytes cultured under either condition (not shown). mGluR5, however, was expressed in the astrocyte cultures. Although there was little or no mGluR5 present in membranes prepared from DMEM + 10% FCS cultures, the antibody recognized a strong band at approximately 145 kDa in an equivalent amount of membrane protein from ADM cultures (Fig. 2) . Thus, a large induction in the level of mGluR5 correlates with the increased ability of trans-(+)-ACPD to stimulate PI hydrolysis. The results obtained with this relatively simple manipulation of the culture medium demonstrate that expression of the mGluR subtypes is plastic in astrocytes, depending upon the composition of the extracellular environment.
Effect of growth .factors on trans-(-t)-ACPD stimulation qf PI hidrol& -
We next explored the reason for these large differences in signal transduction properties and mGluR expression between the two culture conditions, investigating the effects of specific components of the ADM. For each culture condition we determined both basal (unstimulated) and agonist-stimulated 'H-IP, accumulation, corrected for total incorporation of radiolabel, and expressed these values as fold over basal. were run on SDS-PAGE electrophoresis, and transferred to membranes. Blots were probed with an antibody directed against the C-terminus of mGluR5. Following incubation with a goat anti-rabbit secondary antibody coupled to HRP, immunoreactive bands were visualized with enhanced chemiluminescence.
D-biotin, sodium selenite, fibronectin, heparan sulfate, and insulin. These components were added to help maintain healthy cultures but they did not produce a significant alteration in the ability of the astrocytes to respond to trans-(+)-ACPD as compared to astrocytes cultured in DMEM + 10% FCS (Fig. 3) . Addition of either EGF or bFGF to this serum-free control medium increased the ability of trans-(-C)-ACPD to stimulate PI hydrolysis (Fig. 3) . EGF appeared to be more efficacious in this regard than bFGE This was confirmed by examining the response to tram-( t)-ACPD after culturing with varying concentrations of either EGF or bFGE EGF produced its maximal effect at a concentration of 2.5 rig/ml, while the maximal effect of bFGF was not achieved until 30 rig/ml (Fig. 4) . Additionally, the maximal response to trans-( ?)-ACPD in EGF-supplemented cultures appeared to be greater than that in bFGF-supplemented cultures. Each of these growth factors induced radical alterations in astrocyte morphology, producing a stellate shape with numerous long and highly branching processes. Although expression of the EGF receptor (EGF-R) in astrocytes in brain has been well documented, EGF mRNA appears to be expressed only at low levels, and some studies have failed to detect EGF with immunohistological methods (as discussed (Lazar and Blum, 1992) . In contrast, TGF-ol, a structural homolog of EGF that displays similar affinity for the EGF-R ( Derynck, 1992) , is widely expressed in brain at significantly higher levels than EGF (Kaser et al., 1992; Lazar and Blum, 1992) . Since TGF-a may be a more physiologically prevalent ligand, the ability of this growth factor to enhance astrocyte responsivity to trans-(F)-ACPD was also examined. As with EGF, culturing with TGF-a produced a large increase in the PI response stim-40-l Figure 3 . Effect of growth factors on the ability of truns-(t)-ACPD to stimulate PI hydrolysis. Basic FGF (5 ng/ ml), EGF (10 rig/ml), or TGF-o( (10 ng/ ml) were added to a minimally supplemented serum-free control medium (SF) comprised of DMEM supplemented with transferrin, D-biotin, sodium selenite, fibronectin, heparan sulfate, and insulin. After 3-4 d of exposure to the growth factors, the culture medium was aspirated, the cultures rinsed with bicarbonate buffer, and as- (Fig. 3) and produced a dramatically peared to be more efficacious than bFGF in the induction of stellate morphology. mGluR5.
Effect of growth ~factors on mGluR.5 Sensitivity to pertussis toxin Again, mGluRla Western blotting of equivalent amounts of membrane protein from the various culture conditions showed no expression of this subtype in any of the astrocyte cultures (not shown). In contrast, Western blots for mGluR5 revealed that a small amount of mGluR5 was expressed in the minimally supplemented serum-free cultures while exposure of astrocytes to either EGF, bFGF, or TGF-ol produced a robust increase in the mGluR5 signal (Fig. 5) . As with the PI hydrolysis, EGF apStudies of individual cloned mGluR subtypes expressed in CHO cells have demonstrated that signal transduction via the different subtypes is mediated by either pertussis toxin (PTX)-sensitive or PTX-insensitive G-proteins. For the two subtypes shown to couple to stimulation of PI hydrolysis in CHO cells, mGluRlmediated stimulation is PTX-sensitive (Aramori and Nakanishi, 1992) , while mGluR5-mediated stimulation displays little PTX sensitivity (Abe et al., 1992) . To test the PTX sensitivity of the upregulated PI hydrolysis response in our astrocytes, cultures were grown in the presence of TGF-ol (10 rig/ml) and exposed to PTX (10 rig/ml to 1 Fg/ml) for the final 18 hr of culture.
Concentrations of PTX as high as 1 kg/ml produced little reduction in the ability of 100 FM lS,3R-ACPD (the active enantiomer of trans-(t)-ACPD) to stimulate PI hydrolysis (stimulation was 21.2 t 2.2-fold of basal without PTX treatment and 18.3 t 2.1-fold following PTX treatment; n = 3), suggesting that the G-protein that mediates this effect may be similar to that which couples to phospholipase C in CHO cells expressing mGluR5. In contrast, this same treatment (PTX 1 pg/ml, 18 hr) markedly attenuated stimulation of PI hydrolysis by 100 pM norepinephrine (14.3 2 1.3-fold of basal without PTX vs 7.8 2 1.4-fold of basal following PTX treatment; n = 3) in agreement with previous reports (Wilson and Minneman, 1990; Marin et al., 1993) .
2oi T Quisqualate
Glutamate lS,3R-ACPD Figure 5 . Western blotting demonstrates that exposure to specific growth factors can induce mGluR5. After 3%4 d of exposure to the growth factors, membrane fractions were prepared, fractionated by SDS-PAGE, and Western blots were conducted with an antibody selective for mGluR5. EGF or bFGF at the concentrations used in ADM (10 rig/ml and 5 nglml, respectively) was added to a minimally supplemented serum-free control medium (SF). The effect of TGF-ol was also tested by addition to the serum-free medium at 10 rig/ml. For comparison, at left, immunoreactivity in a rat brain cortex sample (C7X).
Speci&dy to mGluR agonists
To determine whether other neurotransmitter receptors were upregulated in the same manner, astrocytes were grown in either serum-free medium in the presence or absence of TGF-a and stimulated with norepinephrine, the cholinergic agonist carbach-01, or mGluR agonists (Fig. 6 ). For each of the mGluR agonists tested-glutamate, quisqualate, and 1 S,3R-ACPD-the stimulation of PI hydrolysis was greatly enhanced by culturing in the presence of TGF-(r. However, exposure to TGF-a produced little difference in the ability of norepinephrine or carbachol to stimulate PI hydrolysis, demonstrating that the enhancement in response to mGluR agonists was not a generalized phenomenon of other transmitter systems and suggesting that the growth factor treatment did not produce a nonspecific increase in the synthesis of all proteins.
Culture Condition H Without TGF-a n +TGF-a Norepinephrine Carbachol Figure 6 . TGF-IY. selectively enhanced mGluR agonist-induced PI hydrolysis. Comparison of agonist stimulation of PI hydrolysis in sister cultures of secondary astrocytes grown in serum-free medium in either the absence or presence of TGF-ol (10 rig/ml) for 4-5 d. 
Discussion
Using electron microscopic immunocytochemistry, mGluR.5 has been demonstrated to be present in some astrocytic processes in rat brain van den Pol and Romano, unpublished) . The present in vitro results demonstrate that PI signal transduction and the expression of mGluR5 in astrocytes are plastic and can be modified according to the precise growth factor composition of the extracellular environment.
We have shown that EGF, bFGE or TGF-o will induce a robust increase in mGluR5 levels, while mGluRla remains undetectable. Although artificial expression of individual cloned receptor subtypes in CHO and BHK cells has been instructive in defining the pharmacology of specific receptor subtypes, the transduction machinery present in these cells may differ from that of neurons and astrocytes. The culture technique demonstrated here provides a useful in vitro system for studying mGluR5 pharmacology and signal transduction in a CNS cell type (Miller et al., 1994) . In addition, this method will be useful for studying the significance of mGluR5 activation in regulating astrocyte function.
EGE TGF-cc, and bFGF are all astrocyte mitogens. However, the increased truns-ACPD stimulation of PI hydrolysis is not merely a reflection of increases in cell number because the values for HIP, were normalized to total incorporation of radiolabel and expressed as stimulation over basal levels of PI hydrolysis in identically cultured cells. The mitogenic effect of these growth factors was also accounted for in the Western blot studies by running equal amounts of membrane protein per lane. Additionally, the elevated mGluR5 levels are not a reflection of a generalized upregulation in protein expression because functional measures of other PI-coupled neurotransmitter receptors were not similarly increased (Fig. 6) . Further, in a separate series of experiments we have demonstrated that treatment of these cultures with mitogens like bFGF does not upregulate message levels for an unrelated protein, the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (E Gomez-Pinilla et al, unpublished). The selective upregulation of mGluR5 after exposure to these growth factors does, however, suggest that this receptor is in some way associated with cell cycle progression. The present study does not directly address the mechanism through which mGluR5 levels are altered; however, considerable recent progress has been made in characterizing the signal transduction cascade initiated via EGF and FGF receptors. These receptors have integral tyrosine kinase domains, which, when activated, lead to Ras activation and the subsequent initiation of an intracellular cascade of phosphorylation resulting in activation of mitogen activated protein kinases (MAP kinases) and alterations in gene transcription (Guan, 1994; Moodie and Wolfman, 1994; Marshall, 1995) . Modulation of the expression levels of glutamate receptor subtypes may be relevant to the roles specific growth factors have in the CNS in development, differentiation, and response to injury. EGF and bFGF, synthesized in both neurons and astrocytes, enhance neuronal survival and neurite outgrowth in culture and promote survival following injury in vivo (PlataSalaman, 1991; Logan and Berry, 1993) . TGF-a, a more abundant hgand for the EGF-R (Kaser et al., 1992; Lazar and Blum, 1992) is also expressed in both neurons and glia (Seroogy et al., 1993) . Interestingly, the regional distribution of mRNA for TGF-o in mature brain (Kaser et al., 1992; Lazar and Blum, 1992; Seroogy et al., 1993) correlates well with the distribution of mGluR5 mRNA (Abe et al., 1992; Testa et al., 1994) . Developmentally, in situ hybridization studies demonstrate that TGF-(IU mRNA expression is greater in the early postnatal period than in the adult brain (Seroogy et al., 1993) , displaying a similar developmental decrease as mGluR5 message levels (Abe et al., 1992) and protein (Roman0 et al., unpublished) .
Expression of bFGF, EGF, and TGF-o and their receptors in astrocytes in vivo indicates that the potential exists for mGluR5 expression to be controlled in the CNS by means similar to those that we have demonstrated in culture.
TGF-a, the EGF-R, and bFGF have been shown to be elevated in a variety of pathological states in the CNS, such as after ischemia and after chemical or mechanical lesions (Junier et al., 199 I, 1994; Plata-Salaman, 199 1; Logan and Berry, I 993; Kornblum et al., 1994) . Further, addition of bFGF or ligands for the EGF-R to our astrocyte cultures produced a morphology similar to the morphology of astrocytes undergoing reactive astrogliosis in vim. It is also relevant to note here that treatments that have previously been reported to increase excitatory amino acid stimulated PI hydrolysis in ex viva brain slices (lesions, Nicoletti et al., 1987; ischemia, Seren et al., 1989; and kindling, Iadorola et al., 1986) are accompanied by astrogliosis. Those studies, combined with the present in vitro results, lead us to speculate that mGluR5 expression may also be altered during in vivo astrogliosis. If so, it will be important to examine the functional consequences of such a change with regards to the astrocytic response to injury, particularly since disruptions of glutamate homeostasis may be involved in many pathological conditions in the CNS (Coyle and Puttfarcken, 1993; Lipton and Rosenberg, 1994) . Preliminary studies in our lab indicate that activation of mGluR5 with truns-ACPD enhances astrocyte proliferation, suggesting a role for this receptor in the progression of astrogliosis. Indeed, the ability of neurotransmitters that stimulate PI hydrolysis to produce trophic effects has been demonstrated in other systems, for example, in fibroblasts transfected with serotonin receptor subtypes (Lauder, 1993) . Growth factors, neurotrophins, cytokines, and other substances are released by neurons and glia and can act in both autocrine and paracrine fashions. In the present study we demonstrate a novel type of growth factor-neurotransmitter interaction in which specific growth factors selectively regulate the levels of a subtype of neurotransmitter receptor, thereby strengthening the subsequent efficacy of that neurotransmitter on a specific signal transduction pathway. This type of signal pairing, between a growth factor and a neurotransmitter, may represent a form of conditioning of the astrocytic response. Other examples of cellular conditioning effects have been demonstrated in electrophysiological studies of neuronal function, for example, the depolarization-dependent relief of the magnesium blockade of the N-methyl-D-aspartate receptor channel (as reviewed, Cotman et al., 1988) . In comparison, the present work demonstrates a mechanistically distinct type of conditioning of the astrocyte response to glutamate in which the magnitude of a second-messenger response is dependent upon prior exposure of the astrocytes to specific growth factors that regulate receptor subtype levels. Alteration in the ratios of receptors by the changing growth factor composition of the microenvironment would then modify future signalling properties and cell-cell interactions, influencing the net physiological results following glutamate release. In this way, neurons may direct astrocytic responses over a prolonged time course to modify the function of local cellular groups.
